CN101428041A - Cordyceps sinensis extract, preparation method and uses in preparing medicament - Google Patents
Cordyceps sinensis extract, preparation method and uses in preparing medicament Download PDFInfo
- Publication number
- CN101428041A CN101428041A CNA2008100515981A CN200810051598A CN101428041A CN 101428041 A CN101428041 A CN 101428041A CN A2008100515981 A CNA2008100515981 A CN A2008100515981A CN 200810051598 A CN200810051598 A CN 200810051598A CN 101428041 A CN101428041 A CN 101428041A
- Authority
- CN
- China
- Prior art keywords
- cordyceps
- parts
- extract
- extraction
- add
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000284 extract Substances 0.000 title claims abstract description 39
- 238000002360 preparation method Methods 0.000 title abstract description 13
- 239000003814 drug Substances 0.000 title abstract description 10
- 241001248610 Ophiocordyceps sinensis Species 0.000 title description 6
- 241000190633 Cordyceps Species 0.000 claims abstract description 52
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 47
- 238000000605 extraction Methods 0.000 claims abstract description 19
- 239000003826 tablet Substances 0.000 claims description 24
- 239000000706 filtrate Substances 0.000 claims description 19
- 239000006187 pill Substances 0.000 claims description 18
- 241001264174 Cordyceps militaris Species 0.000 claims description 15
- 239000000203 mixture Substances 0.000 claims description 15
- 239000007919 dispersible tablet Substances 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 12
- 239000003795 chemical substances by application Substances 0.000 claims description 11
- 239000000463 material Substances 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 239000000843 powder Substances 0.000 claims description 8
- 239000000945 filler Substances 0.000 claims description 7
- 239000008187 granular material Substances 0.000 claims description 7
- 239000000314 lubricant Substances 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 6
- 238000005550 wet granulation Methods 0.000 claims description 5
- 239000000853 adhesive Substances 0.000 claims description 4
- 230000001070 adhesive effect Effects 0.000 claims description 4
- 238000010438 heat treatment Methods 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 3
- 239000007779 soft material Substances 0.000 claims description 3
- 239000002671 adjuvant Substances 0.000 claims description 2
- 229960004756 ethanol Drugs 0.000 claims 2
- 239000000758 substrate Substances 0.000 claims 2
- 239000002253 acid Substances 0.000 claims 1
- 230000001476 alcoholic effect Effects 0.000 claims 1
- 229960000935 dehydrated alcohol Drugs 0.000 claims 1
- 239000012467 final product Substances 0.000 claims 1
- 230000004927 fusion Effects 0.000 claims 1
- 238000000465 moulding Methods 0.000 claims 1
- 238000010298 pulverizing process Methods 0.000 claims 1
- 238000012958 reprocessing Methods 0.000 claims 1
- 238000002604 ultrasonography Methods 0.000 claims 1
- 150000004676 glycans Chemical class 0.000 abstract description 9
- 229920001282 polysaccharide Polymers 0.000 abstract description 9
- 239000005017 polysaccharide Substances 0.000 abstract description 9
- 238000003809 water extraction Methods 0.000 abstract description 4
- 238000009776 industrial production Methods 0.000 abstract description 3
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 230000004071 biological effect Effects 0.000 abstract description 2
- 239000002994 raw material Substances 0.000 abstract description 2
- 239000002904 solvent Substances 0.000 abstract description 2
- 239000007788 liquid Substances 0.000 description 15
- 238000003860 storage Methods 0.000 description 9
- 238000009210 therapy by ultrasound Methods 0.000 description 8
- 239000004480 active ingredient Substances 0.000 description 6
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 6
- 239000006185 dispersion Substances 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 239000011159 matrix material Substances 0.000 description 5
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 4
- 239000011230 binding agent Substances 0.000 description 4
- 238000004090 dissolution Methods 0.000 description 4
- 238000007689 inspection Methods 0.000 description 4
- 229940016286 microcrystalline cellulose Drugs 0.000 description 4
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 4
- 239000008108 microcrystalline cellulose Substances 0.000 description 4
- 239000008107 starch Substances 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- 238000009833 condensation Methods 0.000 description 3
- 230000005494 condensation Effects 0.000 description 3
- 235000019359 magnesium stearate Nutrition 0.000 description 3
- 238000002137 ultrasound extraction Methods 0.000 description 3
- 229920003081 Povidone K 30 Polymers 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- AMTWCFIAVKBGOD-UHFFFAOYSA-N dioxosilane;methoxy-dimethyl-trimethylsilyloxysilane Chemical compound O=[Si]=O.CO[Si](C)(C)O[Si](C)(C)C AMTWCFIAVKBGOD-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 2
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 229940083037 simethicone Drugs 0.000 description 2
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 2
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 2
- 239000007939 sustained release tablet Substances 0.000 description 2
- 238000009736 wetting Methods 0.000 description 2
- MYKOKMFESWKQRX-UHFFFAOYSA-N 10h-anthracen-9-one;sulfuric acid Chemical compound OS(O)(=O)=O.C1=CC=C2C(=O)C3=CC=CC=C3CC2=C1 MYKOKMFESWKQRX-UHFFFAOYSA-N 0.000 description 1
- -1 40.0 parts Polymers 0.000 description 1
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 description 1
- 241001480006 Clavicipitaceae Species 0.000 description 1
- 229920002785 Croscarmellose sodium Polymers 0.000 description 1
- 206010014561 Emphysema Diseases 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- CTKXFMQHOOWWEB-UHFFFAOYSA-N Ethylene oxide/propylene oxide copolymer Chemical compound CCCOC(C)COCCO CTKXFMQHOOWWEB-UHFFFAOYSA-N 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- 229920001030 Polyethylene Glycol 4000 Polymers 0.000 description 1
- 208000004403 Prostatic Hyperplasia Diseases 0.000 description 1
- 229960004998 acesulfame potassium Drugs 0.000 description 1
- 235000010358 acesulfame potassium Nutrition 0.000 description 1
- 239000000619 acesulfame-K Substances 0.000 description 1
- VJHCJDRQFCCTHL-UHFFFAOYSA-N acetic acid 2,3,4,5,6-pentahydroxyhexanal Chemical compound CC(O)=O.OCC(O)C(O)C(O)C(O)C=O VJHCJDRQFCCTHL-UHFFFAOYSA-N 0.000 description 1
- 102000011759 adducin Human genes 0.000 description 1
- 108010076723 adducin Proteins 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 229960005168 croscarmellose Drugs 0.000 description 1
- 239000001767 crosslinked sodium carboxy methyl cellulose Substances 0.000 description 1
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 238000007922 dissolution test Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 210000005003 heart tissue Anatomy 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000012982 microporous membrane Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 229920001993 poloxamer 188 Polymers 0.000 description 1
- 229940044519 poloxamer 188 Drugs 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 229940069328 povidone Drugs 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 201000004240 prostatic hypertrophy Diseases 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000036299 sexual function Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000008247 solid mixture Substances 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
技术领域: Technical field:
本发明涉及一种虫草提取物及其制剂的制备方法,属于中药有效成分提取及应用技术领域,也属于中药制药领域。The invention relates to a preparation method of a cordyceps extract and a preparation thereof, which belongs to the technical field of extraction and application of active ingredients of traditional Chinese medicines, and also belongs to the field of traditional Chinese medicine pharmacy.
背景技术: Background technique:
虫草(Cordyceps militaris),别名北冬虫夏草、北虫草。蛹虫草属子囊菌亚门(Ascomycotina)、麦角菌科(Clavicipitaceae)、虫草属(Cordyceps)。在冬虫夏草供不应求的情况下,与冬虫夏草齐名的蛹虫草在国际上日益受到人们的关注,它的开发和生产为人体保健和医药领域开发了新的营养源和药源。《新华本草纲要》记载蛹虫草“性平,味甘,有益肺肾,补精髓,止血化痰”等功效,用于肺结核、老人虚弱及贫血等症,为珍贵的中药材。蛹虫草具有多种药理作用:能降血脂,防止动脉硬化,保护心、脑组织,镇静催眠,增强巨噬细胞活性,抗癌、抗炎、抗菌、抗缺氧等;蛹虫草可用于治疗肺气肿、前列腺肥大;蛹虫草还能提高机体免疫力,辅助肾移植患者恢复健康,增加性功能等。Cordyceps militaris, also known as Cordyceps militaris, Cordyceps militaris. Cordyceps militaris belongs to Ascomycotina, Clavicipitaceae, Cordyceps. Under the condition that the supply of Cordyceps sinensis is in short supply, Cordyceps militaris, which is as famous as Cordyceps sinensis, has attracted more and more attention in the world. Its development and production have developed new sources of nutrition and medicine for the fields of human health care and medicine. "Compendium of Xinhua Materia Medica" records that Cordyceps militaris is "flat in nature, sweet in taste, beneficial to the lungs and kidneys, nourishing the essence, stopping bleeding and resolving phlegm". Cordyceps militaris has a variety of pharmacological effects: it can lower blood fat, prevent arteriosclerosis, protect heart and brain tissue, calm and hypnotize, enhance macrophage activity, anti-cancer, anti-inflammatory, anti-bacterial, anti-hypoxia, etc.; Cordyceps militaris can be used to treat lung cancer. Emphysema, prostatic hypertrophy; Cordyceps militaris can also improve the body's immunity, assist kidney transplant patients to recover, increase sexual function, etc.
原胶囊剂、片剂的工艺技术特点是将虫草菌体采用水煮醇沉的方法提取虫草菌体中多种蛋白质和多糖类有效成分,有效成分往往提取不完全。The technical feature of the original capsules and tablets is that the Cordyceps fungus is boiled and alcohol-precipitated to extract various active components of proteins and polysaccharides in the Cordyceps fungus, and the active ingredients are often not completely extracted.
发明内容: Invention content:
本发明的目的在于提供一种虫草提取物,含有虫草的有效活性成分。The object of the present invention is to provide an extract of Cordyceps sinensis containing effective active ingredients of Cordyceps sinensis.
本发明还提供了其制备方法,适用于工业化生产。The invention also provides its preparation method, which is suitable for industrial production.
本发明还提供了该虫草提取物在制备药物中的应用,公开了相应的滴丸、分散片及缓释片药物剂型。The invention also provides the application of the Cordyceps extract in the preparation of medicines, and discloses the corresponding dosage forms of dropping pills, dispersible tablets and slow-release tablets.
本发明的虫草提取物,可以通过以下方法得到的:Cordyceps extract of the present invention can be obtained by the following methods:
取蛹虫草冻干菌丝粉和10-30%乙醇按1:15-40(W/V)比例混合,40—60℃进行超声波辅助提取,超声波频率为20-40KHz,超声处理时间为30-90分钟,重复处理1-3次,其中乙醇浓度为10-30%;提取结束后,过滤,合并多次滤液,得滤液A;Take the freeze-dried mycelium powder of Cordyceps militaris and 10-30% ethanol and mix them in a ratio of 1:15-40 (W/V), and carry out ultrasonic-assisted extraction at 40-60°C, the ultrasonic frequency is 20-40KHz, and the ultrasonic treatment time is 30- For 90 minutes, repeat the treatment 1-3 times, wherein the ethanol concentration is 10-30%; after the extraction is completed, filter and combine multiple filtrates to obtain filtrate A;
滤渣干燥,以料水比1:30—1:50,于40—60℃下超声处理(超声波频率为20-40KHz)反应2—4小时,得滤液B;The filter residue is dried, and the ratio of material to water is 1:30-1:50, and it is subjected to ultrasonic treatment (ultrasonic frequency is 20-40KHz) at 40-60°C for 2-4 hours to obtain filtrate B;
将滤液A与滤液B混合,在35-45℃,300-700mmHg下减压浓缩,添加95%乙醇或无水乙醇,使溶液中乙醇重量含量为55-90%,静置8-24小时,利用冷冻干燥机干燥成干粉即得。Mix filtrate A and filtrate B, concentrate under reduced pressure at 35-45°C and 300-700mmHg, add 95% ethanol or absolute ethanol, make the ethanol weight content in the solution 55-90%, let stand for 8-24 hours, It can be obtained by drying into dry powder with a freeze dryer.
表1 不同提取方法对虫草多糖提取率的影响Table 1 Effect of different extraction methods on the extraction rate of Cordyceps polysaccharide
本发明的虫草滴丸方法,包括以下步骤:Cordyceps dripping pill method of the present invention comprises the following steps:
将虫草提取物与基质按照1份:(1~9)份的配比,置于加热容器内边搅拌边加热,直至得到含有药物提取物和基质的熔融液备用,调整滴丸机的温度控制系统,使滴丸机贮液瓶的温度保持在50℃~90℃,冷凝剂的温度保持在5℃~20℃,待滴丸机贮液瓶和冷凝柱内冷凝剂的温度分别稳定达到所要求的温度状态时,将含有虫草提取物和基质的熔融液置于滴丸机的贮液瓶内,滴入冷凝剂中成型。Put the Cordyceps extract and base in a ratio of 1 part: (1-9) parts, place in a heating container and heat while stirring until a molten liquid containing the drug extract and base is obtained, and adjust the temperature control of the dropping pill machine system, keep the temperature of the liquid storage bottle of the dropping pill machine at 50°C-90°C, and the temperature of the condensing agent at 5°C-20°C, and wait until the temperatures of the liquid storage bottle of the dropping pill machine and the condensation column are stable to reach the required temperature respectively. At the required temperature state, put the molten liquid containing the Cordyceps extract and the matrix in the liquid storage bottle of the dropping pill machine, and drop it into the condensing agent to form it.
本发明的虫草分散片方法,包括以下步骤:Cordyceps dispersible tablet method of the present invention comprises the following steps:
将虫草提取物和辅料粉碎,过80~200目筛,取虫草提取物10~30份,加入5~70份的崩解剂、10~85份的填充剂、加5~30份的润湿粘合剂制成合适的软材,过20-40目筛制粒,在40~80℃的温度下烘干,20-40目筛整粒,在制得的干颗粒中加入1~3份的润滑剂,混合均匀,压片即得,优选片剂硬度控制在4-7kg。Crush the Cordyceps extract and auxiliary materials, pass through a 80-200 mesh sieve, take 10-30 parts of Cordyceps extract, add 5-70 parts of disintegrant, 10-85 parts of filler, add 5-30 parts of wetting The binder is made into a suitable soft material, granulated through a 20-40 mesh sieve, dried at a temperature of 40-80°C, sized with a 20-40 mesh sieve, and 1-3 parts are added to the prepared dry granules lubricant, mixed evenly, and tableted to obtain, the preferred tablet hardness is controlled at 4-7kg.
本发明的虫草缓释片制备方法,包括以下步骤:The preparation method of Cordyceps sustained-release tablet of the present invention comprises the following steps:
取20.0~60.0份的虫草提取物,加入10.0~70.0份的缓释材料和5.0~50.0份的填充剂,混匀,经粉碎后过80~120目筛;加入适量粘合剂,采用干法或湿法制粒、整粒,加入1.0~3.0份的润滑剂混匀,压片机压片,制成含有效主药量的缓释片剂即可。Take 20.0-60.0 parts of Cordyceps extract, add 10.0-70.0 parts of slow-release material and 5.0-50.0 parts of filler, mix well, pass through 80-120 mesh sieve after crushing; add appropriate amount of adhesive, use dry method Or wet granulation, granulation, adding 1.0 to 3.0 parts of lubricant, mixing evenly, tableting with a tablet machine, to make slow-release tablets containing effective main drug amount.
本发明相对现有虫草有效成分的提取方法物相比具有的积极效果如下:运用了超声波处理、醇提与水提相结合的提取方法,超声处理可以提高有效成分的提取,醇提与水提相结合既可以提高有效成分的提取率,又可以节省溶剂,从而保证了虫草多糖的生物活性,最大限度地增加了原料的利用率,降低了生产成本,适合大规模工业化生产。Compared with the existing extraction method of active ingredients of Cordyceps sinensis, the present invention has the following positive effects: the extraction method combining ultrasonic treatment, alcohol extraction and water extraction is used, ultrasonic treatment can improve the extraction of active ingredients, alcohol extraction and water extraction The combination can not only improve the extraction rate of active ingredients, but also save solvents, thereby ensuring the biological activity of the polysaccharide of Cordyceps, maximizing the utilization rate of raw materials, reducing production costs, and being suitable for large-scale industrial production.
具体实施方式: Detailed ways:
实施例1Example 1
取蛹虫草冻干菌丝粉100g,按1∶40(W/V)的比例加入10~30%乙醇混合,40℃进行超声波辅助提取,超声波频率为40KHz,超声处理时间为60分钟,重复处理3次,其中乙醇浓度分别为10%、20%、30%;提取结束后,过滤,合并多次滤液,得滤液A;Take 100g of Cordyceps militaris freeze-dried mycelium powder, add 10~30% ethanol to mix at a ratio of 1:40 (W/V), carry out ultrasonic-assisted extraction at 40°C, the ultrasonic frequency is 40KHz, and the ultrasonic treatment time is 60 minutes, and the treatment is repeated 3 times, wherein the ethanol concentration was 10%, 20%, and 30% respectively; after the extraction was completed, filter, and combine multiple filtrates to obtain filtrate A;
滤渣干燥,以料水比1:30,于40℃下超声处理,超声波频率为30KHz,反应4小时,得滤液B;The filter residue was dried, and the ratio of material to water was 1:30, and ultrasonic treatment was carried out at 40°C, the ultrasonic frequency was 30KHz, and the reaction was carried out for 4 hours to obtain the filtrate B;
将滤液A与滤液B混合,在35-45℃,700mmHg下减压浓缩,添加95%乙醇或无水乙醇,使溶液中乙醇重量含量为55%,静置24小时,使水溶性蛹虫草粗多糖析出;利用冷冻干燥机干燥成干粉即得。Filtrate A is mixed with filtrate B, concentrated under reduced pressure at 35-45°C and 700mmHg, adding 95% ethanol or absolute ethanol, making the ethanol weight content in the solution 55%, standing for 24 hours, and making the water-soluble Cordyceps militaris thick The polysaccharide is precipitated; it is obtained by drying into a dry powder with a freeze dryer.
实施例2Example 2
取蛹虫草冻干菌丝粉100g按1∶15(W/V)的比例加入10~30%乙醇混合,60℃进行超声波辅助提取,超声波频率为20-40KHz,超声处理时间为90分钟,重复处理3次,其中乙醇浓度为分别为10%、20%、30%;提取结束后,过滤,合并多次滤液,得滤液A;Take 100g of Cordyceps militaris freeze-dried mycelium powder and add 10-30% ethanol in the ratio of 1:15 (W/V) to mix, and carry out ultrasonic-assisted extraction at 60°C. The ultrasonic frequency is 20-40KHz, and the ultrasonic treatment time is 90 minutes. Repeat Treat 3 times, wherein the ethanol concentration is respectively 10%, 20%, and 30%; after the extraction is completed, filter and combine multiple filtrates to obtain filtrate A;
滤渣干燥,以料水比1:50,于60℃下超声处理,超声波频率为40KHz,反应3小时,得滤液B;The filter residue was dried, and the ratio of material to water was 1:50, and ultrasonic treatment was carried out at 60°C, the ultrasonic frequency was 40KHz, and the reaction was carried out for 3 hours to obtain the filtrate B;
将滤液A与滤液B混合,在35-45℃,300mmHg下减压浓缩,添加95%乙醇或无水乙醇,使溶液中乙醇重量含量为90%,静置12小时,使水溶性蛹虫草粗多糖析出;利用冷冻干燥机干燥成干粉即得。Filtrate A is mixed with filtrate B, concentrated under reduced pressure at 35-45°C and 300mmHg, adding 95% ethanol or absolute ethanol, making the ethanol weight content in the solution 90%, standing for 12 hours, and making the water-soluble Cordyceps militaris thick The polysaccharide is precipitated; it is obtained by drying into a dry powder with a freeze dryer.
实施例3:虫草滴丸Embodiment 3: Cordyceps dripping pills
1.虫草提取物:取实施例1制备得虫草提取物。1. Cordyceps extract: take the Cordyceps extract prepared in Example 1.
2.制备方法:取虫草提取物100份,与100份PEG4000混匀,置于加热容器内边搅拌边加热,直至得到含有药物提取物和基质的熔融液备用,调整滴丸机的温度控制系统,使滴丸机的贮液瓶加热并保持在70℃~80℃,冷凝剂的温度保持在5℃~8℃,待滴丸机贮液瓶和冷凝柱内冷凝剂的温度分别稳定达到所要求的温度状态时,将含有虫草浸膏和基质的熔融液置于滴丸机的贮液瓶内,滴入冷凝剂二甲基硅油中成型。2. Preparation method: Take 100 parts of Cordyceps extract, mix it with 100 parts of PEG4000, put it in a heating container and heat it while stirring until the molten liquid containing the drug extract and matrix is obtained, and adjust the temperature control system of the dropping pill machine , heat the liquid storage bottle of the dropping pill machine and keep it at 70°C to 80°C, keep the temperature of the condensing agent at 5°C to 8°C, and wait until the temperature of the condensing agent in the liquid storage bottle and the condensation column of the dropping pill machine reaches the required temperature respectively. At the required temperature state, put the molten liquid containing Cordyceps extract and matrix in the liquid storage bottle of the dropping pill machine, and drop it into the condensing agent simethicone oil to form.
实施例4:Example 4:
1.虫草提取物:取实施例2制备得虫草提取物。1. Cordyceps extract: take the Cordyceps extract prepared in Example 2.
2.制备方法:取虫草提取物100份,与300份泊落沙姆188混匀,置于加热容器内边搅拌边加热,直至得到含有药物提取物和基质的熔融液备用,调整滴丸机的温度控制系统,使滴丸机的贮液瓶加热并保持在70℃~80℃,冷凝剂的温度保持在5℃~8℃,待滴丸机贮液瓶和冷凝柱内冷凝剂的温度分别稳定达到所要求的温度状态时,将含有虫草浸膏和基质的熔融液置于滴丸机的贮液瓶内,滴入冷凝剂二甲基硅油中成型。2. Preparation method: Take 100 parts of Cordyceps extract, mix with 300 parts of Poloxamer 188, place in a heating container and heat while stirring until a molten liquid containing the drug extract and matrix is obtained, then adjust the dropping pill machine The temperature control system makes the liquid storage bottle of the dropping pill machine heated and kept at 70°C-80°C, the temperature of the condensing agent is kept at 5°C-8°C, and the temperature of the condensing agent in the liquid storage bottle of the dropping pill machine and the condensation column When the required temperature states are stably reached respectively, the molten liquid containing the Cordyceps extract and the matrix is placed in the liquid storage bottle of the dropping pill machine, and dropped into the condensing agent simethicone to form.
实施例5:虫草分散片Embodiment 5: Cordyceps dispersible tablet
处方:成份(重量百分比含量)Prescription: ingredients (weight percentage content)
虫草提取物20份、淀粉32份、羧甲基纤维素钠15份、交联羧甲基淀粉10份、微晶纤维素15份、安塞蜜2份、聚维酮K30乙醇5份、微粉硅胶1份;20 parts of Cordyceps extract, 32 parts of starch, 15 parts of sodium carboxymethyl cellulose, 10 parts of croscarmellose starch, 15 parts of microcrystalline cellulose, 2 parts of acesulfame potassium, 5 parts of povidone K30 ethanol, micropowder 1 part of silica gel;
取实施例1制得的虫草提取物和上述处方中的辅料过100目筛粉碎处理,再将虫草提取物与羧甲基纤维素钠,交联羧甲基淀粉钠,微晶纤维素,淀粉充分混合均匀,采用5%的聚维酮K30乙醇溶液作为润湿粘合剂,将上述固体混合物制成软材,20目筛制粒于60℃烘干,20目筛整粒,加入微粉硅胶混匀,控制片剂重量,压片,即得虫草分散片。Get the Cordyceps extract obtained in Example 1 and the adjuvant in the above prescription and pass through a 100 mesh sieve to pulverize, then mix the Cordyceps extract with sodium carboxymethyl cellulose, cross-linked sodium carboxymethyl starch, microcrystalline cellulose, and starch Mix well, use 5% povidone K30 ethanol solution as a wetting adhesive, make the above solid mixture into a soft material, granulate with a 20-mesh sieve and dry at 60°C, granulate with a 20-mesh sieve, add micropowder silica gel Mix well, control the weight of the tablet, and compress the tablet to obtain the Cordyceps dispersible tablet.
实施例得到的分散片均匀性检查:在20±1℃水中,全部崩解并通过2号筛的时间不大于140秒,符合规定。Uniformity inspection of the dispersible tablets obtained in the examples: in water at 20±1°C, the time for them to completely disintegrate and pass through the No. 2 sieve is not more than 140 seconds, which meets the regulations.
关于本发明分散片的分散均匀性和溶出度的检查方法如下。The inspection method about the dispersion uniformity and dissolution rate of the dispersible tablet of the present invention is as follows.
①分散片的分散均匀性的检查:按中国药典2005版二部附录IA分散片剂项下要求检查,取本发明分散片2片,置于100ml水中振摇,在20±1℃水中,3分钟应全部崩解通过2号筛,采用装置可按中国药典2005版二部附录XA片剂项下仪器装置的要求检查。1. The inspection of the uniformity of dispersion of the dispersible tablet: check by the requirements of the Chinese Pharmacopoeia 2005 edition two appendix IA dispersible tablet item, get 2 dispersible tablets of the present invention, shake in 100ml water, in 20 ± 1 ℃ of water, 3 Minutes should all disintegrate and pass through the No. 2 sieve, and the device used can be checked according to the requirements of the device under the Chinese Pharmacopoeia 2005 edition, Appendix XA tablet item.
本发明分散均匀性的测定:The mensuration of dispersion uniformity of the present invention:
表2.虫草分散片的分散均匀性检查结果Table 2. Dispersion uniformity inspection results of Cordyceps dispersible tablets
②分散片的溶出度检查:取本品,照中国药典2005年版二部附录溶出度测定第二法进行。转速为100r/min,介质为900ml脱气去离子水,温度为37±0.5℃,定时取样5ml,经微孔滤膜(0.45um)滤过,同时补充相同体积和相同温度的去离子水。续滤液经硫酸蒽酮法测定多糖浓度,计算累积释放量,限度为标示量的80%,应符合规定。② Dissolution test of dispersible tablets: take this product, and carry out according to the second method of dissolution determination in the second appendix of the Chinese Pharmacopoeia 2005 edition. The rotation speed is 100r/min, the medium is 900ml degassed deionized water, the temperature is 37±0.5°C, 5ml is sampled regularly, filtered through a microporous membrane (0.45um), and deionized water of the same volume and temperature is added at the same time. The subsequent filtrate was tested for polysaccharide concentration by the sulfate anthrone method, and the accumulated release amount was calculated, and the limit was 80% of the marked amount, which should meet the regulations.
表3.虫草分散片与普通虫草片剂的溶出度比较Table 3. Comparison of dissolution rates between Cordyceps dispersible tablets and common Cordyceps tablets
由表1、2的试验数据可以看出,虫草分散片的崩解分散性能完全符合标准,溶出性能明显优于普通片。From the test data in Tables 1 and 2, it can be seen that the disintegration and dispersion properties of the Cordyceps dispersible tablets fully meet the standards, and the dissolution performance is obviously better than that of ordinary tablets.
实施例6 虫草缓释片Example 6 Cordyceps sustained-release tablet
处方:虫草提取物150.0份、羟丙甲基纤维素80.0份、乙基纤维素67.0份、Prescription: Cordyceps extract 150.0 parts, hydroxypropyl methylcellulose 80.0 parts, ethyl cellulose 67.0 parts,
微晶纤维素50.0份、硬脂酸镁3.0份、50%乙醇20份50.0 parts of microcrystalline cellulose, 3.0 parts of magnesium stearate, 20 parts of 50% ethanol
制备方法:称取所述份量的虫草提取物,加入所述份量的缓释材料和填充剂,混匀,均粉碎后过80~120目筛;加入适量粘合剂,采用湿法制粒,用18目筛整粒,40~60℃干燥1~2小时后取出,加入所述份量的润滑剂混匀,压片机压片,制成片重0.5g的缓释片,即得。Preparation method: weigh the Cordyceps extract of the stated amount, add the slow-release material and the filler of the stated amount, mix well, grind them evenly and pass through a 80-120 mesh sieve; add an appropriate amount of binder, adopt wet granulation, and use Sieve with 18 meshes, dry at 40-60°C for 1-2 hours, take out, add the stated amount of lubricant, mix well, and press into tablets with a tablet machine to make slow-release tablets with a tablet weight of 0.5 g.
实施例7Example 7
处方:虫草提取物150.0份、羟丙甲基纤维素60.0份、甲基纤维素45.0份、Prescription: Cordyceps extract 150.0 parts, hydroxypropyl methylcellulose 60.0 parts, methyl cellulose 45.0 parts,
微晶纤维素92.0份、硬脂酸镁3.0份、50%乙醇20份92.0 parts of microcrystalline cellulose, 3.0 parts of magnesium stearate, 20 parts of 50% ethanol
制备方法:称取所述份量的虫草提取物,加入所述份量的缓释材料和填充剂,混匀,均粉碎后过80~120目筛;加入适量粘合剂,采用湿法制粒,用18目筛整粒,40~60℃干燥1~2小时后取出,加入所述份量的润滑剂混匀,压片机压片,制成片重0.5g的缓释片,即得。Preparation method: weigh the Cordyceps extract of the stated amount, add the slow-release material and the filler of the stated amount, mix well, grind them evenly and pass through a 80-120 mesh sieve; add an appropriate amount of binder, adopt wet granulation, and use Sieve with 18 meshes, dry at 40-60°C for 1-2 hours, take out, add the stated amount of lubricant, mix well, and press into tablets with a tablet machine to make slow-release tablets with a tablet weight of 0.5 g.
实施例8Example 8
处方:虫草提取物150.0份、羟丙纤维素、40.0份、聚维酮25.0份、Prescription: Cordyceps extract 150.0 parts, hydroxypropyl cellulose, 40.0 parts, povidone 25.0 parts,
乳糖132.0份、硬脂酸镁3.0份、50%乙醇20份132.0 parts of lactose, 3.0 parts of magnesium stearate, 20 parts of 50% ethanol
制备方法:称取所述份量的虫草提取物,加入所述份量的缓释材料和填充剂,混匀,均粉碎后过80~120目筛;加入适量粘合剂,采用湿法制粒,用18目筛整粒,40~60℃干燥1~2小时后取出,加入所述份量的润滑剂混匀,压片机压片,制成片重0.5g的缓释片,即得。Preparation method: weigh the Cordyceps extract of the stated amount, add the slow-release material and the filler of the stated amount, mix well, grind them evenly and pass through a 80-120 mesh sieve; add an appropriate amount of binder, adopt wet granulation, and use Sieve with 18 meshes, dry at 40-60°C for 1-2 hours, take out, add the stated amount of lubricant, mix well, and press into tablets with a tablet machine to make slow-release tablets with a tablet weight of 0.5 g.
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNA2008100515981A CN101428041A (en) | 2008-12-12 | 2008-12-12 | Cordyceps sinensis extract, preparation method and uses in preparing medicament |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNA2008100515981A CN101428041A (en) | 2008-12-12 | 2008-12-12 | Cordyceps sinensis extract, preparation method and uses in preparing medicament |
Publications (1)
Publication Number | Publication Date |
---|---|
CN101428041A true CN101428041A (en) | 2009-05-13 |
Family
ID=40643809
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2008100515981A Pending CN101428041A (en) | 2008-12-12 | 2008-12-12 | Cordyceps sinensis extract, preparation method and uses in preparing medicament |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101428041A (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101766662B (en) * | 2010-01-07 | 2012-05-23 | 南京中科药业有限公司 | Process for efficiently concentrating cordyceps sinensis mycelia |
CN102499435A (en) * | 2011-11-02 | 2012-06-20 | 深圳市大百汇技术有限公司 | Cordyceps militaris extraction method and cigarette containing cordyceps militaris extract |
CN103432172A (en) * | 2013-08-23 | 2013-12-11 | 周秋火 | Cordyceps sinensis tablets |
WO2017084029A1 (en) * | 2015-11-17 | 2017-05-26 | 罗明镜 | Method for extracting cordyceps sinensis extract |
WO2017084030A1 (en) * | 2015-11-17 | 2017-05-26 | 罗明镜 | Method for extracting cordyceps sinensis extract |
CN113546097A (en) * | 2021-07-21 | 2021-10-26 | 广东省科学院微生物研究所(广东省微生物分析检测中心) | Application of ethanol extract of cordyceps guangdongensis fruiting body in preparation of medicine for preventing obesity and hyperlipidemia |
-
2008
- 2008-12-12 CN CNA2008100515981A patent/CN101428041A/en active Pending
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101766662B (en) * | 2010-01-07 | 2012-05-23 | 南京中科药业有限公司 | Process for efficiently concentrating cordyceps sinensis mycelia |
CN102499435A (en) * | 2011-11-02 | 2012-06-20 | 深圳市大百汇技术有限公司 | Cordyceps militaris extraction method and cigarette containing cordyceps militaris extract |
CN102499435B (en) * | 2011-11-02 | 2014-01-01 | 深圳市大百汇技术有限公司 | Cigarette containing cordyceps militaris extract |
CN103432172A (en) * | 2013-08-23 | 2013-12-11 | 周秋火 | Cordyceps sinensis tablets |
WO2017084029A1 (en) * | 2015-11-17 | 2017-05-26 | 罗明镜 | Method for extracting cordyceps sinensis extract |
WO2017084030A1 (en) * | 2015-11-17 | 2017-05-26 | 罗明镜 | Method for extracting cordyceps sinensis extract |
CN113546097A (en) * | 2021-07-21 | 2021-10-26 | 广东省科学院微生物研究所(广东省微生物分析检测中心) | Application of ethanol extract of cordyceps guangdongensis fruiting body in preparation of medicine for preventing obesity and hyperlipidemia |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101428041A (en) | Cordyceps sinensis extract, preparation method and uses in preparing medicament | |
CN101574323B (en) | Migltol microcapsule tablet and preparation method thereof | |
JP2016539955A (en) | Drug composition, method for producing the same, and use | |
CN103285070A (en) | Preparation method and application of chickpea sprout extract dispersible tablet | |
WO2015081703A1 (en) | Solid dispersion containing desmodium styracifolium (osb.) merr. flavonoids, method of preparing same, and use thereof | |
CN103263395A (en) | Telmisartan tablet preparation and preparation method thereof | |
CN101129513B (en) | A method for preparing Yixinone sustained-release preparation by using separation-preparation coupling technology | |
CN103860502B (en) | A kind of tablet containing moxonidine hydrochloride and preparation method thereof | |
CN104398657A (en) | Preparation method of calyx seu fructus physalis dispersing tablet | |
CN104906160A (en) | A kind of enteric-coated preparation of breviscapine extract | |
CN106798867B (en) | A kind of Smilax china L ball and its preparation technology | |
CN109157525A (en) | A kind of amitriptyline hydrochloride tablet agent and preparation method thereof | |
CN111437263B (en) | Corncob total flavone solid dispersion osmotic pump tablet and preparation method thereof | |
CN101095709A (en) | Panax notoginseng floral leaf effervescent tablets and method for preparing the same | |
CN102670711A (en) | White flower salviae miltiorrhizae extract for curing angiitis, preparation method and application | |
CN102793802B (en) | Callicarpa nudiflora dispersible tablet and preparation method thereof | |
CN103463453B (en) | A kind of Dendrobium nobile tablet and preparation method thereof | |
CN1850171A (en) | Method for preparing rhubarb formula granules | |
CN102302545A (en) | Dai medicine extract with blood-sugar reducing activity, preparation method, composition and application | |
CN101766683B (en) | Salvia dispersible tablet and application thereof | |
CN104138363A (en) | Nifedipine sustained-release tablet and preparation method thereof | |
CN104042715B (en) | Dahurian rose fruit dispersible tablet and preparation method thereof | |
CN100548322C (en) | A kind of antitumor medicine composition and preparation method thereof | |
CN101579396A (en) | Euphorbia humifusa dispersing tablet and preparation process thereof | |
CN116173033B (en) | Piperazine ferulate solid oral preparation and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C12 | Rejection of a patent application after its publication | ||
RJ01 | Rejection of invention patent application after publication |
Open date: 20090513 |